90 results
Page 2 of 5
8-K
EX-99.1
mtgfi ofuy5lag
30 Oct 23
Other Events
5:24pm
8-K
EX-99.2
zgcyzvqujofw jbex1k6
30 Oct 23
Other Events
5:24pm
424B5
81xpahjd8enoe
1 Sep 23
Prospectus supplement for primary offering
4:30pm
S-3
oi0m6b8 lx2s6n5
14 Aug 23
Shelf registration
6:05pm
8-K
EX-99.1
ic6e4s
8 Aug 23
MAIA Biotechnology Reports Second Quarter 2023 Financial Results and Provides Updates for THIO-101 Phase 2 Trial for Non-Small Cell Lung Cancer
8:15am
DRS
d317b1c
1 Jun 23
Draft registration statement
12:00am
8-K
EX-1.1
6f3si2
27 Apr 23
MAIA Biotechnology, Inc. Announces Pricing of Public Offering
5:25pm
424B4
krr 7mkrqqdmq
25 Apr 23
Prospectus supplement with pricing info
7:45pm
8-K
EX-99.1
vybud08w0z3n7 ygdz
20 Apr 23
MAIA Biotechnology Reports Preliminary Survival Data in Part A of THIO-101 Phase 2 Trial for Non-Small Cell Lung Cancer
8:43am
DEF 14A
fx3s 72njhj
19 Apr 23
Definitive proxy
4:06pm
8-K
EX-99.1
76x4steo2wjspkxcwvu
18 Apr 23
MAIA Biotechnology Announces Excellent
11:39am
8-K
EX-99.1
8hj6fhk 1p3
11 Apr 23
MAIA Biotechnology Reports Positive Topline Data from Part A Safety Lead-In of THIO-101 Phase 2 Trial for Non-Small Cell Lung Cancer
8:15am